Many new and potentially life-saving medicines require safety monitoring in the form of blood tests. But from audits, we know that such monitoring occurs less than 40% of the time. This could be so much higher with the right software.

Monitoring patients with chronic diseases should never be a manual process, especially in an overburdened healthcare system. Audits show that less than 50% of cancer patients are monitored safely. Tomorrow’s outcomes could be so much better with software.

Nine in 10 diagnostic pathways rely on blood tests. Today, this system is slow, wasteful of hospital resources, error prone and often inconvenient for patients. It’s time to switch from a manual process to a digital solution.